NLRP3 and COVID-19: NLRP3 inflammasome activation of nonclassical monocytes was elevated with increasing COVID-19 severity, while CD66b+CD16dim granulocytes exhibited lower NLRP3 activation potential in severe forms of COVID-19 than mild cases.